Related Experiment Video
Updated: Feb 7, 2026

10:41
A Tuberculosis Molecular Bacterial Load Assay TB-MBLA
Published on: April 30, 2020
14.8K
Induced Mutation Proves a Potential Target for TB Therapy: A Molecular Dynamics Study on LprG
Kgothatso E Machaba1, Ndumiso N Mhlongo2, Mahmoud E S Soliman3
1Molecular Modelling and Drug Design Research Group, School of Health Sciences, University of KwaZulu-Natal, Westville, Durban, 4001, South Africa.
Cell Biochemistry and Biophysics
|August 4, 2018
Summary
Molecular dynamics simulations reveal that the V91W mutation enhances the stability and flexibility of Mycobacterium tuberculosis-LprG (Mtb-LprG). This finding supports Mtb-LprG as a promising target for developing new antimycobacterial drugs.
Area of Science:
- * Computational biophysics and structural biology.
- * Antimycobacterial drug discovery and target identification.
Background:
- * Mycobacterium tuberculosis-LprG (Mtb-LprG) is a potential target for antimycobacterial therapies.
- * Understanding the structural and dynamic impact of mutations is crucial for drug development.
Purpose of the Study:
- * To investigate the effects of the V91W mutation on Mtb-LprG stability and dynamics using molecular dynamics (MD) simulations.
- * To elucidate the role of Mtb-LprG as a potential antimycobacterial target.
Main Methods:
- * Long-range molecular dynamics (MD) simulations of wild-type and V91W mutant Mtb-LprG.
- * Post-simulation analyses including root mean square fluctuation (RMSF), dynamic cross-correlation, and principal component analysis (PCA).
- * Thermodynamic calculations and residue interaction network analysis to assess binding free energy and interactions.
Main Results:
- * The V91W mutant Mtb-LprG exhibited greater stability and flexibility compared to the wild-type.
- * MD simulations indicated increased residual flexibility and negatively correlated motions in the V91W mutant.
- * Thermodynamic analysis showed van der Waals (Evdw) forces significantly contribute to binding free energy in the V91W mutant.
Conclusions:
- * The V91W mutation positively impacts Mtb-LprG stability and dynamics, reinforcing its potential as an antimycobacterial target.
- * This study provides a foundation for identifying novel drug targets against tuberculosis.
- * The findings support Mtb-LprG as a viable target for developing new antimycobacterial agents.
Related Concept Videos
Spontaneous and Induced Mutations
2.3K
Spontaneous mutations arise infrequently during DNA replication due to errors in the process. A key factor behind these errors is tautomeric shifts in nitrogenous bases, where bases transition from keto to enol forms or amino to imino forms. This shift can alter base-pairing rules, leading to mutations. Additionally, reactive oxygen species (ROS) arising from aerobic metabolism can damage DNA, resulting in depurination (loss of a purine base) or depyrimidination (loss of a pyrimidine base).
2.3K
Targeted Cancer Therapies
8.9K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
8.9K
Mutations
94.5K
Overview
94.5K
Mutations
44.6K
Mutations are changes in the sequence of DNA. These changes can occur spontaneously or they can be induced by exposure to environmental factors. Mutations can be characterized in a number of different ways: whether and how they alter the amino acid sequence of the protein, whether they occur over a small or large area of DNA, and whether they occur in somatic cells or germline cells.
Chromosomal Alterations Are Large-Scale Mutations
While point mutations are changes in a single nucleotide in...
Chromosomal Alterations Are Large-Scale Mutations
While point mutations are changes in a single nucleotide in...
44.6K
Viral Mutations
39.9K
A mutation is a change in the sequence of bases of DNA or RNA in a genome. Some mutations occur during replication of the genome due to errors made by the polymerase enzymes that replicate DNA or RNA. Unlike DNA polymerase, RNA polymerase is prone to errors because it is not capable of “proofreading” its work. Viruses with RNA-based genomes, like HIV, therefore accrue mutations faster than viruses with DNA-based genomes. Because mutation and recombination provide the raw material...
39.9K
Gene Therapy
27.6K
Gene therapy is a technique where a gene is inserted into a person’s cells to prevent or treat a serious disease. The added gene may be a healthy version of the gene that is mutated in the patient, or it could be a different gene that inactivates or compensates for the patient’s disease-causing gene. For example, in patients with severe combined immunodeficiency (SCID) due to a mutation in the gene for the enzyme adenosine deaminase, a functioning version of the gene can be...
27.6K

